



|                                                      |  Low (N=67)  | Mild (N=80)  |  High (N=66)  | Total (N=213) | p value|
|:-----------------------------------------------------|:------------:|:------------:|:-------------:|:-------------:|-------:|
|**Vaccine type**                                      |              |              |               |               | < 0.001|
|&nbsp;&nbsp;&nbsp;wP                                  | 51 (76.12%)  | 48 (60.00%)  |  24 (36.36%)  | 123 (57.75%)  |        |
|&nbsp;&nbsp;&nbsp;aP                                  | 10 (14.93%)  | 27 (33.75%)  |  39 (59.09%)  |  76 (35.68%)  |        |
|&nbsp;&nbsp;&nbsp;Both                                |  6 (8.96%)   |  5 (6.25%)   |   3 (4.55%)   |  14 (6.57%)   |        |
|**Coverage of DTP1 (%)**                              |              |              |               |               |   0.254|
|&nbsp;&nbsp;&nbsp;N-Miss                              |      2       |      9       |       7       |      18       |        |
|&nbsp;&nbsp;&nbsp;Median                              |    93.00     |    94.00     |     97.00     |     95.00     |        |
|&nbsp;&nbsp;&nbsp;Q1, Q3                              | 83.00, 98.00 | 87.50, 98.00 | 91.50, 98.50  | 87.00, 98.00  |        |
|**Coverage of DTP3 (%)**                              |              |              |               |               |   0.252|
|&nbsp;&nbsp;&nbsp;N-Miss                              |      2       |      9       |       7       |      18       |        |
|&nbsp;&nbsp;&nbsp;Median                              |    87.00     |    90.00     |     92.00     |     91.00     |        |
|&nbsp;&nbsp;&nbsp;Q1, Q3                              | 77.00, 97.00 | 78.00, 96.00 | 86.00, 97.00  | 78.50, 97.00  |        |
|**General vaccine recommendation**                    |              |              |               |               |   0.086|
|&nbsp;&nbsp;&nbsp;3 doses                             | 25 (37.31%)  | 17 (21.25%)  |  14 (21.21%)  |  56 (26.29%)  |        |
|&nbsp;&nbsp;&nbsp;4 doses                             | 21 (31.34%)  | 19 (23.75%)  |  18 (27.27%)  |  58 (27.23%)  |        |
|&nbsp;&nbsp;&nbsp;5 doses                             | 13 (19.40%)  | 30 (37.50%)  |  20 (30.30%)  |  63 (29.58%)  |        |
|&nbsp;&nbsp;&nbsp;6 doses                             |  8 (11.94%)  | 14 (17.50%)  |  14 (21.21%)  |  36 (16.90%)  |        |
|**General vaccine recommendation for toddlers, -3yr** |              |              |               |               |   0.026|
|&nbsp;&nbsp;&nbsp;3 doses                             | 29 (43.28%)  | 27 (33.75%)  |  37 (56.06%)  |  93 (43.66%)  |        |
|&nbsp;&nbsp;&nbsp;4 doses                             | 38 (56.72%)  | 53 (66.25%)  |  29 (43.94%)  | 120 (56.34%)  |        |
|**General vaccine recommendation for children, 3+yr** |              |              |               |               | < 0.001|
|&nbsp;&nbsp;&nbsp;Not provided                        | 44 (65.67%)  | 30 (37.50%)  |  23 (34.85%)  |  97 (45.54%)  |        |
|&nbsp;&nbsp;&nbsp;1 dose                              | 13 (19.40%)  | 32 (40.00%)  |  16 (24.24%)  |  61 (28.64%)  |        |
|&nbsp;&nbsp;&nbsp;2 doses                             | 10 (14.93%)  | 18 (22.50%)  |  26 (39.39%)  |  54 (25.35%)  |        |
|&nbsp;&nbsp;&nbsp;3 doses                             |  0 (0.00%)   |  0 (0.00%)   |   1 (1.52%)   |   1 (0.47%)   |        |
|**Time of last shot (months)**                        |              |              |               |               | < 0.001|
|&nbsp;&nbsp;&nbsp;Median                              |    18.00     |    48.00     |     72.00     |     48.00     |        |
|&nbsp;&nbsp;&nbsp;Q1, Q3                              | 3.22, 51.00  | 17.25, 84.00 | 18.00, 150.00 | 12.00, 120.00 |        |
|**Vaccine recommendation for pregnant**               |              |              |               |               |   0.027|
|&nbsp;&nbsp;&nbsp;No                                  | 60 (89.55%)  | 61 (76.25%)  |  47 (71.21%)  | 168 (78.87%)  |        |
|&nbsp;&nbsp;&nbsp;Yes                                 |  7 (10.45%)  | 19 (23.75%)  |  19 (28.79%)  |  45 (21.13%)  |        |
|**Vaccine recommendation for adults**                 |              |              |               |               |   0.009|
|&nbsp;&nbsp;&nbsp;No                                  | 62 (92.54%)  | 78 (97.50%)  |  55 (83.33%)  | 195 (91.55%)  |        |
|&nbsp;&nbsp;&nbsp;Yes                                 |  5 (7.46%)   |  2 (2.50%)   |  11 (16.67%)  |  18 (8.45%)   |        |
|**Vaccine recommendation for risk groups**            |              |              |               |               |   0.111|
|&nbsp;&nbsp;&nbsp;No                                  | 61 (91.04%)  | 70 (87.50%)  |  52 (78.79%)  | 183 (85.92%)  |        |
|&nbsp;&nbsp;&nbsp;Yes                                 |  6 (8.96%)   | 10 (12.50%)  |  14 (21.21%)  |  30 (14.08%)  |        |
|**Pertussis status in 2022/2023**                     |              |              |               |               |   0.151|
|&nbsp;&nbsp;&nbsp;N-Miss                              |      9       |      11      |       9       |      29       |        |
|&nbsp;&nbsp;&nbsp;Low                                 | 13 (22.41%)  | 29 (42.03%)  |  25 (43.86%)  |  67 (36.41%)  |        |
|&nbsp;&nbsp;&nbsp;Normal                              | 16 (27.59%)  | 15 (21.74%)  |  11 (19.30%)  |  42 (22.83%)  |        |
|&nbsp;&nbsp;&nbsp;High                                |  2 (3.45%)   |  5 (7.25%)   |   3 (5.26%)   |  10 (5.43%)   |        |
|&nbsp;&nbsp;&nbsp;Resurgence                          | 27 (46.55%)  | 20 (28.99%)  |  18 (31.58%)  |  65 (35.33%)  |        |
